Condition

Kidney Disease, Chronic

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 16 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials16
Recruiting1
Common interventions24
Lead sponsors shown14
Advertisement

Clinical trials

16 shown
Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance DialysisNCT07017270 · 2025-11-27
RECRUITING
Monitoring of the Sympathetic/Vagal Balance Through Multiparametric Analysis of Heart Rate Variability (HRV)NCT07471802 · 2026-05-20
ACTIVE_NOT_RECRUITING
Mesenchymal Stem Cells for Chronic Kidney DiseasesNCT07240987 · 2026-01-01
NOT_YET_RECRUITING
Health Literacy 3D Kidney Model Patient Education TrialNCT06683573 · 2025-02-25
COMPLETED
Food is Medicine vs Lifestyle Medicine For Cardiovascular Kidney Metabolic (CKM) SyndromeNCT06461273 · 2024-10-12
COMPLETED
Semaglutide's Effect on Renal Hemodynamics and Function in Patients With Type 2 Diabetes Mellitus and NephropathyNCT06555146 · 2024-08-01
UNKNOWN
Plant-based Diet for Kidney Transplant RecipientsNCT06186843 · 2024-02-29
ACTIVE_NOT_RECRUITING
Continuous Glucose Monitoring in Patients With Diabetes on Peritoneal DialysisNCT06069518 · 2023-11-01
UNKNOWN
The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKDNCT05374291 · 2022-11-08
ENROLLING_BY_INVITATION
Effect of SGLT2i on Cardiovascular Biomarkers in Patients With Type 2 Diabetes and CKD Stage 3b-4NCT05033054 · 2022-01-01
COMPLETED
The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable DiseasesNCT05248412 · 2021-06-21
UNKNOWN
Randomized Study Comparing Metabolic Surgery With Intensive Medical Therapy to Treat Diabetic Kidney DiseaseNCT04626323 · 2021-05-25
UNKNOWN
Plant Versus Animal Dietary Protein and the Effect on ProteinuriaNCT04058951 · 2019-08-15
UNKNOWN
Cohort Study on Patient Outcomes, Effectiveness and Cost-effectiveness of Intervention Programmes for DM/HT PatientsNCT04302974 · 2019-08-01
COMPLETED
Molecular Analysis of Diabetic Kidney Disease BiopsiesNCT04029402 · 2019-07-01
UNKNOWN
New Heart Failure Biomarkers in Early Stage Chronic Kidney Disease-Mineral and Bone DisorderNCT03307707 · 2015-06-15
COMPLETED

Common interventions

Mapped drugs appearing in these trials

Shared trial participation only; not evidence of efficacy or approval.

Leading sponsors

Trial status mix

UNKNOWN6
COMPLETED5
ACTIVE_NOT_RECRUITING2
ENROLLING_BY_INVITATION1
NOT_YET_RECRUITING1
RECRUITING1

Phase mix

NA5
PHASE22
PHASE11
PHASE31
PHASE41
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.